Business · 17/01/2020Updated: 10/17/2026 · 1 min read
FDA Announces Proposed Collection of Information for Review by Office of Management and Budget
Summary
The Food and Drug Administration is requesting public comment on a proposed collection of information related to biologics licensing and labeling requirements, which has been submitted to the Office of Management and Budget for review and clearance under the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →